app

Paxlovid-Heart Drug Interactions; Turkish Cardiologist Murdered; Permanent PCSK9i?

— Recent developments of interest in cardiovascular medicine

MedpageToday
Electrocardiogram on top and bottom of image with CardioBreak in the center.

In older adults with polypharmacy, drug-drug interactions with nirmatrelvir-ritonavir (Paxlovid) were most commonly reported with . (JAMA Network Open)

Retrospective study suggests survival benefit of early myocardial revascularization in people with inducible myocardial ischemia, . (Journal of the American College of Cardiology)

Healthier versions of could be both palatable and blood pressure-reducing, a randomized trial found. (Circulation)

Some people with , the leading cause of visual impairment in older people, may be more susceptible to cardiovascular disease. (Retina)

A new machine learning-based model of in-hospital mortality in heart failure incorporates . (JAMA Cardiology)

Death of a was associated with an increased risk of mortality within the subsequent few years for people with heart failure, a Swedish registry shows. (JACC: Heart Failure)

A rare genetic variant, found chiefly in people of East Asian descent, makes stroke patients undergoing endovascular therapy . (Stroke: Vascular and Interventional Neurology)

FDA cleared the for smart stethoscopes that can detect valvular heart disease, the company announced.

Cardiology and radiology societies updated the , which now recommends that plaque burden should be estimated whenever present. (Journal of Cardiovascular Computed Tomography)

Pediatric ICUs find to significantly reduce events in-hospital. (JAMA Pediatrics)

expressed common challenges related to a lack of resources, education, and appropriate expectations for recovery. (Journal of the American Heart Association)

Some data challenge conventional thinking on the supposed protective role of in terms of pulmonary vascular disease. (European Heart Journal)

U.K. Biobank study supports a link between excess adiposity and increased LDL cholesterol, likely driven by alone. (The Lancet Regional Health - Europe)

The first person has received investigational that turns off the PCSK9 gene for LDL cholesterol reduction in heterozygous familial hypercholesterolemia, Verve Therapeutics said.

Turkey bans all media coverage of the , and the ensuing strike by medical workers. (Balkan Insight)

Researchers identified as a novel target in heart failure. (Science Translational Medicine)

  • author['full_name']

    Nicole Lou is a reporter for app, where she covers cardiology news and other developments in medicine.